The mechanisms underlying CD4+ T cell depletion in human immunodeficiency virus (HIV) infection are not well understood. Comparative studies of lymphoid tissues, where the vast majority of T cells reside, and peripheral blood can potentially illuminate the pathogenesis of HIV-associated disease. Here, we studied the effect of HIV infection on the activation and depletion of defined subsets of CD4+ and CD8+ T cells in the blood, gastrointestinal (GI) tract, and lymph node (LN). We also measured HIV-specific T cell frequencies in LNs and blood, and LN collagen deposition to define architectural changes associated with chronic inflammation. The major findings to emerge are the following: the GI tract has the most substantial CD4+ T cell depletion at all stages of HIV disease; this depletion occurs preferentially within CCR5+ CD4+ T cells; HIV-associated immune activation results in abnormal accumulation of effector-type T cells within LNs; HIV-specific T cells in LNs do not account for all effector T cells; and T cell activation in LNs is associated with abnormal collagen deposition. Taken together, these findings define the nature and extent of CD4+ T cell depletion in lymphoid tissue and point to mechanisms of profound depletion of specific T cell subsets related to elimination of CCR5+ CD4+ T cell targets and disruption of T cell homeostasis that accompanies chronic immune activation.
Skip Nav Destination
Article navigation
20 September 2004
Article|
September 13 2004
CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract
Jason M. Brenchley,
Jason M. Brenchley
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
Timothy W. Schacker,
Timothy W. Schacker
2Department of Medicine, Division of Surgical Critical Care
Search for other works by this author on:
Laura E. Ruff,
Laura E. Ruff
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
David A. Price,
David A. Price
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
Jodie H. Taylor,
Jodie H. Taylor
3Department of Surgery, Division of Surgical Critical Care
Search for other works by this author on:
Gregory J. Beilman,
Gregory J. Beilman
3Department of Surgery, Division of Surgical Critical Care
Search for other works by this author on:
Phuong L. Nguyen,
Phuong L. Nguyen
5Division of Hematopathology, Mayo Clinic, Rochester, MN 55905
Search for other works by this author on:
Alexander Khoruts,
Alexander Khoruts
2Department of Medicine, Division of Surgical Critical Care
Search for other works by this author on:
Matthew Larson,
Matthew Larson
2Department of Medicine, Division of Surgical Critical Care
Search for other works by this author on:
Ashley T. Haase,
Ashley T. Haase
4Department of Microbiology, University of Minnesota, Minneapolis, MN 55455
Search for other works by this author on:
Daniel C. Douek
Daniel C. Douek
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Search for other works by this author on:
Jason M. Brenchley
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Timothy W. Schacker
2Department of Medicine, Division of Surgical Critical Care
Laura E. Ruff
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
David A. Price
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Jodie H. Taylor
3Department of Surgery, Division of Surgical Critical Care
Gregory J. Beilman
3Department of Surgery, Division of Surgical Critical Care
Phuong L. Nguyen
5Division of Hematopathology, Mayo Clinic, Rochester, MN 55905
Alexander Khoruts
2Department of Medicine, Division of Surgical Critical Care
Matthew Larson
2Department of Medicine, Division of Surgical Critical Care
Ashley T. Haase
4Department of Microbiology, University of Minnesota, Minneapolis, MN 55455
Daniel C. Douek
1Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Bethesda, MD 20892
Address correspondence to D.C. Douek, Human Immunology Section, Vaccine Research Center, National Institutes of Health, 40 Convent Dr., Room 3509, Bethesda, MD 20892. Phone: (301) 594-8484; Fax: (301) 480-2565; email: [email protected]
Abbreviations used in this paper: GI, gastrointestinal; SIV, simian immunodeficiency; TEM cell, effector–memory T cell.
Received:
May 03 2004
Accepted:
August 09 2004
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2004
J Exp Med (2004) 200 (6): 749–759.
Article history
Received:
May 03 2004
Accepted:
August 09 2004
Citation
Jason M. Brenchley, Timothy W. Schacker, Laura E. Ruff, David A. Price, Jodie H. Taylor, Gregory J. Beilman, Phuong L. Nguyen, Alexander Khoruts, Matthew Larson, Ashley T. Haase, Daniel C. Douek; CD4+ T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract . J Exp Med 20 September 2004; 200 (6): 749–759. doi: https://doi.org/10.1084/jem.20040874
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement